Skip to main content

Table 2 Patient data

From: Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning

 

Non-cachexia (n = 50)

Early-cachexia (n = 40)

Late-cachexia (n = 28)

Ages (years)

63.5 ± 11.8

62.1 ± 10.6

59.7 ± 11.3

Female no. (%)

22 (44.4%)

18 (45%)

13 (46.4%)

BMI (kg/m2)

23.9 ± 3.5

20.2 ± 3.1*

18.3 ± 3.4*, #

Serum albumin (g/l)

38.6 ± 4.4

33.7 ± 3.8*

30.1 ± 3.1*, #

Serum triglyceride (mmol/l)

1.3 ± 0.6

1.6 ± 0.9

1.4 ± 0.6

Serum FFA (mmol/l)

0.32 ± 0.18

0.55 ± 0.25*

0.41 ± 0.25 #

Serum IL-6 (pg/ml)

4.6 ± 2.7

7.2 ± 4.3*

13.3 ± 7.4*, #

Serum TNF-α (pg/ml)

6.8 ± 4.4

10.2 ± 5.0

16.7 ± 6.7*, #

  1. *P < 0.05 (early stage cachexia VS. non-cachexia; or late stage cachexia VS. non-cachexia;); #P < 0.05 (late stage cachexia VS. early stage cachexia)